Urokinase Powder

Xi'an Sonwu Biotech Co., Ltd. is one of the most professional manufacturers and suppliers of urokinase powder in China. We warmly welcome yuo to wholesale bulk urokinase powder for sale here from our factory. Quality products and reasonable price are available.

Urokinase Enzyme
Urokinase powder, also known as urinary plasminogen activase (uPA), is a vital plasminogen-activating enzyme that belongs to the serine protease family. It is a polypeptide chain consisting of approximately 411 amino acid residues and is divided into single-chain and two-chain forms. Under physiological conditions, it mainly exists in a single-chain form and is converted to a more active two-chain form through specific cleavage. It is primarily responsible for converting plasminogen into plasmin in the human body, thereby promoting the dissolution of thrombus and maintaining the normal fluidity of the blood system.
It is named after it was first isolated from the urine of humans and animals, but it is widely distributed in the body, including blood, tissues, and cells. It comprises two parts with molecular weights of 33000 (LMW-tcu-PA) and 54000 (HMW-tcu-PA) respectively. It is mainly used as a thrombolytic drug, directly acting on the endogenous fibrinolytic system, and can catalyze the cleavage of plasminogen. The fibrinolytic enzyme can not only degrade fibrin clots but also degrade fibrinogen, coagulation factor V, and coagulation factor VIII in the blood circulation, thereby exerting a thrombolytic effect and having a rapid and effective impact on newly formed thrombi. It can also increase vascular ADPase activity, inhibit ADP-induced platelet aggregation, and prevent thrombosis. Due to its ability to break blood clots, uPA was immediately employed in clinical settings to treat a variety of blood clot-related illnesses, including cerebral thrombosis and myocardial infarction. If you have more questions about uPA powder, please get in touch with Xi'an Sonwu. Xi'an Sonwu can provide you with raw urokinase.

Certificate Of Analysis

Where To Buy Urokinase
Xi'an Sonwu Biotech Co. Ltd. has more than ten years of industry experience, specializing in producing and selling raw materials. Xi'an Sonwu has established solid and reliable partnerships with countries in America, Asia, Europe, and Oceania. Xi'an Sonwu puts product quality first and strives to provide every customer with high-quality services to meet their needs fully.
Every stage of the Xi'an Sonwu production process, beginning with the meticulous selection of raw materials, is tightly regulated. High-quality products are Xi'an Sonwu's top priority, and the company's dedication to perfection is seen in all aspects of its operations, including the selection of raw materials, manufacturing processes, sample testing, and staff professionalism. Xi'an Sonwu may reduce expenses without sacrificing quality by carefully monitoring every detail, guaranteeing that clients receive items of remarkable value.
Xi'an Sonwu is proud of the positive feedback it has received from customers, who have consistently recognized the quality of the products. To further prove product confidence, Xi'an Sonwu will provide samples for you to test.

Customers' Good Comment

What Is The Mechanism Of Action Of Urokinase
Urokinase powder is a serine protease that plays a crucial role in promoting the breakdown of blood clots. It works by transforming plasminogen into plasmin, an enzyme that breaks down fibrin, the primary protein found in blood clots. This process, called fibrinolysis, is critical for dissolving blood clots and maintaining healthy blood flow.
uPA binds directly to plasminogen in the blood, changing its molecular structure from an inactive state to plasmin with high fibrinolytic activity. This process is the starting point of uPA's action and the key to its thrombolytic effect. uPA binds to its specific receptors on the cell surface upon activation, forming a complex that converts plasminogen to plasmin. One essential step in the start of fibrinolysis is the activation of plasminogen. Plasmin cleaves the fibrin, disrupting the clot structure and promoting its dissolution. The activation of plasminogen by uPA is a two-step process. Initially, uPA forms a complex with its receptor, uPA receptor (uPAR), which binds plasminogen tightly. This interaction causes a conformational change in plasminogen, converting it into active plasmin. This process occurs locally to the clot, allowing precise control of fibrinolysis.
uPA-mediated fibrinolysis is a tightly regulated process that ensures clot dissolution occurs at the appropriate time and location. Various molecular interactions affect plasminogen activation by including plasminogen binding to fibrin and other clot components. These interactions help localize plasminogen activation to the clot site, minimizing off-target effects. uPA is engaged in several physiological processes in addition to fibrinolysis. The activity of uPA is regulated by many factors in the body to ensure the accuracy and safety of its action. For example, α2-antiplasmin (α2-antiplasmin) can quickly inhibit plasmin activity and prevent the potential risk of bleeding caused by excessive thrombus dissolution. In addition, plasminogen activator inhibitor (PAI-1) can regulate uPA activity and maintain fibrinolytic balance in the body.

What Is The Function Of Urokinase
1. Plasminogen activation
One of the main functions of uPA is to activate plasminogen. Plasminogen is an inactive protein in the blood that needs to be converted into active plasmin through uPA. This process is a critical step in the activation of the fibrinolytic system.

2. Fibrinolysis
By activating plasminogen, uPA generates plasmin, an enzyme that breaks down fibrin in the thrombus. Fibrin is the main component of thrombosis, and plasmin rapidly dissolves and removes thrombus in blood vessels by breaking it down into lytic products.

3. Dissolution of thrombus
The action of uPA leads to the breakdown of fibrin and, ultimately, the dissolution of the entire thrombus. That is essential to restore normal blood flow, prevent blood vessel blockage, and reduce tissue damage.

4. Treat thrombotic diseases
When there is an acute arterial blockage, such as when treating thrombotic conditions, including acute myocardial infarction, cerebrovascular accident (stroke), and pulmonary embolism, uPA is used chiefly clinically. It works to save tissue by dissolving blood clots and quickly restoring blood flow.

5. Maintain smooth blood vessels
uPA helps maintain blood vessel patency through plasmin production and fibrin dissolution. That has important implications for preventing and treating thrombosis-related diseases like venous and arterial thrombosis.

6. Participate in tissue repair
The activation of the fibrinolytic system is used to dissolve thrombi and participates in tissue repair and regeneration processes. The role of uPA helps regulate the balance of the fibrinolytic system, thereby affecting the repair of tissue damage.

What Is The Difference Between Streptokinase And Urokinase
Streptokinase and uPA are both enzymes used in medical settings for thrombolytic therapy, which involves the dissolution of blood clots. While they share the common goal of promoting fibrinolysis, there are notable differences between streptokinase and uPA regarding their sources, mechanisms of action, and clinical applications.

1. Source
Streptokinase: Streptokinase is derived from beta-hemolytic streptococci bacteria. It is produced by certain strains of streptococci, primarily Streptococcus pyogenes.
uPA: It is a naturally occurring enzyme in the human body. The kidneys and other tissues produce it. uPA, used for medical purposes, is often obtained from human urine or made through recombinant DNA technology.

2. Mechanism of Action
Streptokinase: Streptokinase acts indirectly by forming a complex with plasminogen. This complex then converts other plasminogens into plasmin, the active enzyme breaking down fibrin clots. It has a broad spectrum of action.
uPA: on the other hand, it directly activates plasminogen into plasmin. It has a more focused action than streptokinase and is specific to plasminogen activation.

3. Specificity
Streptokinase: Streptokinase is less specific and can activate plasminogen from various species, including humans, rats, and rabbits.
uPA: It is more specific to human plasminogen, making it relatively more selective in its action within the human body.

4. Clinical Applications
Streptokinase: Streptokinase treats various thrombotic conditions, such as acute myocardial infarction (heart attack), pulmonary embolism, and deep vein thrombosis. However, its use may be limited by its potential to induce an immune response in some patients.
uPA: It is also used for thrombolytic therapy, especially in acute ischemic stroke, pulmonary embolism, and other conditions where rapid clot dissolution is required. It tends to have a more limited immune response compared to streptokinase.

5. Immunogenicity
Streptokinase: Streptokinase can be immunogenic, which may stimulate an immune response in the body. This immune response can reduce its efficacy upon repeated use.
uPA: It is less immunogenic, making it more suitable for repeated administration.

Factory
1. Xi'an Sonwu Biotech Co., Ltd has a factory to produce, manufacture, and store the products, so it has adequate stock. Xi'an Sonwu has a well-ordered, clean, and tidy production department. Under Xi'an Sonwu, researchers can continuously develop high-quality new products.
2. Xi'an Sonwu has strict requirements on personnel allocation from production and testing to sales. To ensure that each product is escorted, rigorous data support and after-sales service are provided.

Certificate

Package

Logistics

Besides guaranteeing the product, the other most important thing is customers can receive the goods smoothly. So, Xi'an Sonwu supplies all kinds of couriers according to different needs.

FAQ
Please note that bleeding may occur during clinical treatment, including bleeding at venipuncture sites, wounds and nosebleeds, hematuria, and sometimes skin or mucous membrane bleeding. In severe cases, visceral bleeding, especially intracranial bleeding, can be life-threatening. Allergic reactions, such as fever, headache, nausea, vomiting, facial flushing, eyelid edema, urticaria, etc., may occur. In severe cases, anaphylactic shock may occur.
If you want to know the uPA manufacturer, you can contact Xi'an Sonwu. Click the email, and then you get high-quality urokinase powder.
Email: sales@sonwu.com

Hot Tags: urokinase powder, China, suppliers, manufacturers, factory, wholesale, buy, price, bulk, pure, raw, supply, for sale, Metformin Hcl Powder, API Powder Clotrimazole, Sirolimus Powder, 9-ME-BC Powder, NAD Powder, Pyrazinamide Powder